title: [Coronary artery bypass grafting for cardiovascular sequelae in Kawasaki disease].
abstract: There are several issues regarding surgical revascularization for Kawasaki coronary disease including (1) the choice of conduits and (2) the optimal timing and correct indication for coronary artery bypass grafting(CABG). The internal thoracic artery(ITA) is the best conduit in terms of growth potential for pediatric CABG and for excellent long-term patency. The use of saphenous vein graft should be avoided unless an ITA is unavailable. The indication of CABG for Kawasaki coronary disease has not been established. In principle, coronary aneurysms should be observed continuously for 1 to 2 years under restrictive anticoagulation therapy, because regression of coronary aneurysm often occurs in 50 % within 1 to 2 years. The presence of severe ischemia in giant coronary aneurysms involving either the left main trunk or left anterior descending coronary artery is an absolute indicator for CABG. In addition, giant aneurysms with recurrent thrombosis under restrictive anticoagulation therapy or with severe delayed flow without significant localized stenosis may be an indication for CABG.
authors.forename: Yuji
authors.initials: Y
authors.lastname: Maruyama
authors.forename: Masami
authors.initials: M
authors.lastname: Ochi
mesh_terms: D002318:Cardiovascular Diseases / Q000209:etiology / Q000601:surgery*; D001026:Coronary Artery Bypass; D006801:Humans; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications*; D017410:Practice Guidelines as Topic